Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GS.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GS.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GS.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GS.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GS.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.3.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FT.3.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.3.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FT.3.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FT.3.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FT.3.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FT.3.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.3.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.4.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.4.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.4.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.4.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.4.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JZ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JZ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JZ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JZ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JZ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HS.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HS.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HS.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HS.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HS.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.73EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.73EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.73ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.73ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.73EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.73EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.73ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.73ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.2.86.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.86.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used